Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Nesuparib is a dual inhibitor of the poly(ADP-ribose) polymerases PARP1/2 and tankyrases TNKS1/2.1 It reduces the proliferation of Capan-1 pancreatic ductal adenocarcinoma (PDAC) cells with an IC50 value of 0.1895 µM. Nesuparib (0.01-1 µM) selectively inhibits the proliferation of, and induces apoptosis and G2/M phase cell cycle arrest in, HPAF-II and AsPC-1 PDAC cells expressing RNF43 loss-of-function mutations over SNU-410 PDAC cells expressing wild-type RNF43. Nesuparib (50 mg/kg) also reduces tumor growth in a Capan-1 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. JPI-